AIBotics Launches First Pilot Program with One of Miami’s Elite Fitness Centers to Introduce Phill Robot™ in High-End Recovery Lounges
Rhea-AI Summary
AIBotics (OTC: AIBT), a subsidiary of Ehave Inc. (OTC: EHVVF), has launched its first pilot program for Phill Robot™ at Rule Fitness, an elite Miami fitness center. The AI-powered massage robot features a patented foldable arm with a 35-inch range and 15-pound massage force, delivering personalized massage therapy without requiring specialized attire.
The launch aligns with significant market opportunities, as the global massage equipment market is projected to reach $42.5 billion by 2032. The AI industrial robotics market is expected to grow to $66.5 billion by 2030, with a 25% CAGR, while the global AI market is forecast to expand from $640 billion in 2024 to over $3.7 trillion by 2034.
Positive
- None.
Negative
- Initial rollout limited to single location pilot program
- Operating in highly competitive market with established players
- Trading on OTC markets rather than major exchanges
News Market Reaction 1 Alert
On the day this news was published, AIBT declined 22.86%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Phill Robot™ debuts in Miami’s premier high-performance recovery lounge, delivering advanced AI massage without specialized attire, as AIBotics launches the first of many pilot programs with chiropractors, health clubs, and retirement homes, targeting multi-billion-dollar markets in massage equipment, robotics, and artificial intelligence
MIAMI, Aug. 19, 2025 (GLOBE NEWSWIRE) -- AIBotics (OTC: AIBT) (“AIBotics” or the “Company”), a developer and manager of AI- and robotics-enhanced technologies and a subsidiary of Ehave, Inc. (OTC: EHVVF), today announced it has signed an agreement with Rule Fitness, one of Miami’s premier fitness and wellness facilities, to launch a pilot program introducing the Phill Robot™ into elite recovery lounges.
Rule Fitness is known for combining elite physical training with mental conditioning and advanced recovery programs. The facility offers members a holistic experience designed to sharpen focus, push physical limits, and recharge through exceptional wellness services.
“Recovery rooms are becoming an essential feature in modern fitness facilities and offer more than just relaxation, they accelerate muscle recovery, improve mobility, and enhance overall wellness, which is why we built a dedicated recovery lounge,” said Elie Neufeld, founder of Rule Fitness. “Integrating Phill Robot™ gives our members advanced, accessible massage therapy, and as part of AIBotics’ pilot program, it shows how recovery lounges can keep people healthier, happier, and more engaged.”
The Phill Robot™ features a patented foldable arm with a 35-inch range and 15-pound massage force, and doubles as a nightstand when not in use. Phill Robot™ delivers a tailored massage experience for every user, offering settings that range from gentle relaxation to intensive deep-tissue recovery. Unlike other massage robots, Phill Robot™ does not require any special clothing, allowing users to enjoy a personalized massage without the need for specialized attire.
Ben Kaplan, CEO of AIBotics, said, “The addressable market for AIBotics is substantial, and our pilot program with Rule Fitness marks the commercialization of Phill Robot™. This phase of our business plan comes on the heels of Aescape Inc. announcing it raised
The global massage equipment market was valued at
With Phill Robot™, AIBotics aims to capitalize on the convergence of these trends, offering a device that integrates AI precision with user convenience in both professional and home wellness settings.
About AIBotics
AIBotics, Inc. develops and manages AI- and robotics-enhanced technologies designed to solve real-world challenges. Its flagship product, the Phill Robot™, is an AI-powered massage robot that delivers spa-quality recovery with IoT integration. The Company is also focused on the next generation of artificial intelligence—systems capable of making independent decisions, managing complex tasks, and achieving outcomes without direct human input. To accelerate this vision, AIBotics has partnered to co-develop a next-generation autonomous operating platform.
Blending hardware expertise with a growing AI software stack, AIBotics is positioning itself as a leader in personal robotics, healthcare, wellness, and hospitality. The Company is expanding e-commerce distribution and pilot programs for Phill while also investing in R&D for its intelligent assistant platform.
For more information on AIBotics, visit https://www.aibotics.ai or on X.com (formerly Twitter).
About Rule Fitness
Rule Fitness is a high-performance training and wellness facility in North Miami Beach, Florida, offering elite coaching, cutting-edge recovery services, and a results-driven environment for serious athletes and motivated individuals. Its team of world-class professionals, including experts in fitness, bodybuilding, health, wellness, and nutrition, is committed to helping members achieve their goals in body, mind, and life. For more information on Rule Fitness, visit https://rulemiami.com/home or on Instagram.
Forward-Looking Statement Disclaimer
This press release contains “forward-looking statements” within the meaning of applicable securities legislation. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions, opinions and estimates of management and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the U.S. Food and Drug Administration and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise, except as required by applicable law.
For Media and Investor Relations, please contact:
David L. Kugelman
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Email: dk@atlcp.com